Editorials

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies

Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
Haematologica Early view Aug 20, 2026 https://doi.org/10.3324/haematol.2026.301677